Skip to content

Diagnostic Study of Multiple Pulmonary Nodules by Integrating Liquid Biopsy with CT-AI

Diagnostic Study of Multiple Pulmonary Nodules by Integrating Liquid Biopsy with CT-AI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064001
Enrollment
Unknown
Registered
2022-09-23
Start date
2022-09-22
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Pulmonary Nodules

Interventions

Gold Standard:Pathologic diagnosis from biopsies or surgical resections.
Index test:MDA test, CT-AI

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years, both male and female; 2. No less than 2 nodules >= 4mm on Chest CT scans; 3. Size of the predominate nodules (the nodule with the largest diameter) <= 30mm; 4. Multiple nodules suspected as multiple pulmonary cancer, metastasis of lung/non-lung cancer, or multiple benign lesions; 5. At least 2 target lesions with pathological diagnosis available; 6. Consent to blood sample collection (prior to invasive procedures); 7. DICOM formatted files of CT images are available.

Exclusion criteria

Exclusion criteria: 1. Females in pregnancy or lactation; 2. Patients in severe conditions including organ dysfunction, infection or hypo-immunity; 3. Given no consent to study entry or unable to complete the study due to subjective or objective reasons.

Design outcomes

Primary

MeasureTime frame
Discrimination;Calibration;Overall Performance;

Countries

China

Contacts

Public ContactCheng Yue

West China Hospital, Sichuan University

chengyue-6@163.com+86 15902844094

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026